Response Modifiers: Tweaking the Immune Response Against Influenza A Virus
Despite causing pandemics and yearly epidemics that result in significant morbidity and mortality, our arsenal of options to treat influenza A virus (IAV) infections remains limited and is challenged by the virus itself. While vaccination is the preferred intervention strategy against influenza, its...
Main Authors: | Husni Elbahesh, Thomas Gerlach, Giulietta Saletti, Guus F. Rimmelzwaan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.00809/full |
Similar Items
-
Recombinant influenza A viruses as vaccine vectors
by: Thomas Gerlach, et al.
Published: (2019-04-01) -
Influenza Virus Infections and Cellular Kinases
by: Robert Meineke, et al.
Published: (2019-02-01) -
Diverse roles of lung macrophages in the immune response to influenza A virus
by: Haoning Li, et al.
Published: (2023-09-01) -
FDA-Approved Inhibitors of RTK/Raf Signaling Potently Impair Multiple Steps of In Vitro and Ex Vivo Influenza A Virus Infections
by: Robert Meineke, et al.
Published: (2022-09-01) -
Schisandra chinensis (Turcz.) Baill. polysaccharide inhibits influenza A virus in vitro and in vivo
by: Jing Qi, et al.
Published: (2023-10-01)